CollPlant Biotechnologies (CLGN) EBITDA Margin Growth (3y) (2020 - 2026)
CollPlant Biotechnologies (CLGN) EBITDA Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | -507,983.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -507,983.00 |
| Dec 31, 2025 | 281,207.00 |
| Sep 30, 2025 | -45,546.00 |
| Jun 30, 2025 | 811,633.00 |
| Dec 31, 2024 | -119,607.00 |
| Sep 30, 2024 | -11.13 Mn |
| Jun 30, 2024 | 221,275.00 |
| Mar 31, 2024 | 434,820.00 |
| Dec 31, 2023 | -160,371.00 |
| Sep 30, 2023 | -1,771.00 |
| Jun 30, 2023 | 28,819.00 |
| Mar 31, 2023 | 109,300.00 |
| Dec 31, 2022 | -747,073.00 |
| Sep 30, 2022 | -384,179.00 |
| Jun 30, 2022 | -663,150.00 |
| Dec 31, 2021 | -124,660.00 |
| Sep 30, 2021 | -289,304.00 |
| Jun 30, 2021 | -120,646.00 |
| Mar 31, 2021 | -85,797.00 |
| Dec 31, 2020 | -74,036.00 |